Does Wellcare Cover Farxiga?
The verdict
Covered on most plans
Yes — Wellcare (Centene) covers Farxiga for type 2 diabetes, heart failure, and CKD on its 2026 Medicare Part D plans (Value Script and Classic PDPs) and Medicaid managed-care plans. As a Part D sponsor Wellcare is legally required to carry Farxiga at the IRA negotiated Maximum Fair Price of $178.50 per 30-day supply in 2026. On Medicare, prior authorization is near-nil. On Wellcare Managed Medicaid, a metformin-first step therapy is commonly applied before Farxiga is approved. Generic dapagliflozin is now available.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with Wellcare using your member ID.
Key facts
Wellcare must cover Farxiga on its 2026 Medicare Part D plans at the IRA negotiated Maximum Fair Price of $178.50 per 30-day supply, down 68% from approximately $556.
CMS Medicare Drug Price Negotiation Program, 2026 MFP
Wellcare Managed Medicaid commonly applies metformin-first step therapy for Farxiga: 30.6% PA and 25.4% step therapy nationally (MMIT, as of Sept 11, 2025).
MMIT via GoodRx (as of Sept 11, 2025)
Generic dapagliflozin (Farxiga's active ingredient) is now FDA-approved and available — potentially a lower-cost option on Wellcare formularies.
FDA Drug Approvals and Databases
Medicare vs. commercial coverage
Whether Wellcare covers Farxiga depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
Farxiga is covered on Wellcare's 2026 Medicare Part D plans (Value Script and Classic PDPs). Prior authorization and step therapy are essentially nil on Medicare — nationally 0.2% PA and 0.3% step therapy for Farxiga across all Part D plans (MMIT, as of Sept 11, 2025). As a Part D sponsor, Wellcare is required to carry Farxiga at the IRA negotiated Maximum Fair Price of $178.50 per 30-day supply, effective January 1, 2026 (a 68% reduction from approximately $556). Wellcare's Part D plans use a 5–6 tier structure: Tier 1 preferred generic at $0 at preferred pharmacy, Tier 3 preferred brand, and a distinct Tier 6 for select chronic-condition drugs; the $615 plan deductible applies before standard cost-share tiers kick in. The $2,100 annual out-of-pocket cap (CMS 2026 Part D redesign) limits your maximum yearly exposure. AstraZeneca reports an average Medicare Part D out-of-pocket for Farxiga of approximately $38.82 per month (manufacturer-reported, not a guarantee).
Commercial / Employer
Group & marketplace plans
Wellcare has limited commercial and ACA plan offerings relative to its Medicare Part D and Medicaid footprint. Where Wellcare commercial plans are offered, Farxiga is covered (MMIT commercial 92.1%), though commercial step therapy is very high nationally at 45.8% — metformin-first is the norm. ACA plans also carry step therapy (23.6%). Wellcare Managed Medicaid covers Farxiga at 99.8% (MMIT, Sept 11, 2025); PA is required in approximately 30.6% of Medicaid plans and step therapy in 25.4% — usually metformin-first with possible quantity limits. Verify your state Preferred Drug List for Medicaid requirements. Generic dapagliflozin is now available and may be covered at a lower tier — check your Wellcare formulary.
The 3 boxes you must tick to get approved
Commercial plans that will consider Farxiga require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.
Meet all 3 and you have a documented case for approval. Missing any one is the most common reason requests are denied.
Your cost, three ways
What Farxiga actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
Approximately $400–$600+ per 30-day supply at retail pharmacy for brand Farxiga (pharmacy-variable estimate). Generic dapagliflozin is available at lower cost — verify price at your pharmacy.
List price with no coverage — before any manufacturer savings card.
With coverage
Medicare Part D: $615 deductible applies first; then Tier 3 cost-share by plan phase; $2,100 annual out-of-pocket cap in 2026; IRA Maximum Fair Price $178.50 per 30-day supply effective January 1, 2026; AstraZeneca average Part D OOP ~$38.82/month (manufacturer-reported, not a guarantee). Medicaid: $0–$10 nominal cost-share typical. All figures are estimates — confirm with your Wellcare plan.
Typical monthly copay once prior authorization is approved.
All dollar figures are estimates and vary by Wellcare plan tier, pharmacy, state, and benefit phase. Wellcare's 5–6 tier structure means your cost depends on which tier Farxiga lands on for your specific plan. Generic dapagliflozin may be available at a lower tier — check the formulary. AstraZeneca figures are manufacturer-reported averages, not a guarantee of your specific cost. Medicare beneficiaries cannot use commercial copay cards.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Search for Farxiga on Wellcare's online formulary tool
Go to wellcare.com, log in to your member account, and use the drug formulary or drug pricing tool to search for Farxiga (or dapagliflozin). Select your specific 2026 plan to see tier placement, any PA or step-therapy requirement, and estimated cost-share. Also check whether generic dapagliflozin is covered on your plan at a lower tier.
- 2
Ask your prescriber to document metformin history if step therapy applies
If Wellcare's Medicaid or commercial plan requires a metformin-first step, your prescriber must submit documentation of an adequate metformin trial at the highest tolerated dose, or a clinical reason metformin is contraindicated. Your doctor can initiate this process directly through Wellcare's PA portal or by phone. On Medicare, PA is not expected.
- 3
Call Wellcare member services for 2026 cost-share confirmation
Call the member services number on your Wellcare ID card and ask: (1) What tier is Farxiga on my plan? (2) Is step therapy or PA required? (3) Does my plan cover generic dapagliflozin at a lower tier? (4) What is my deductible status and how does the $2,100 cap apply? Your pharmacist can also run a real-time eligibility check.
Options if Wellcare won't cover Farxiga
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
Generic dapagliflozin (Farxiga generic)
FDA-approved generic dapagliflozin is now available and may carry lower cost-share on Wellcare formularies than brand Farxiga. Verify tier on your Wellcare plan's drug list.
Jardiance (empagliflozin)
Another SGLT2 inhibitor for T2D, heart failure, and CKD; no generic yet. The 2026 IRA negotiated price for Jardiance is $197 per 30-day supply. Discuss with your prescriber.
Metformin (generic)
First-line generic diabetes medication; Tier 1 at approximately $4/month. Required as a prior step in many Wellcare Medicaid and commercial plans before Farxiga is approved.
These options are listed for information only — your own clinician decides what is appropriate for you.
❓Frequently Asked Questions
Yes — Wellcare's 2026 Medicare Part D plans (Value Script and Classic PDPs) cover Farxiga. As a Part D sponsor, Wellcare must carry it at the IRA negotiated Maximum Fair Price of $178.50 per 30-day supply, effective January 1, 2026. Prior authorization is not expected on Medicare (0.2% PA nationally per MMIT). Your $615 deductible applies first, and the $2,100 annual out-of-pocket cap limits total yearly exposure.
Yes, commonly. Approximately 30.6% of Medicaid plans nationally require PA for Farxiga and 25.4% require step therapy, usually metformin-first (MMIT, Sept 11, 2025). Wellcare Managed Medicaid plans reflect this pattern and may add quantity limits. Your prescriber must document a metformin trial or contraindication. Requirements vary by state PDL — verify with your specific Wellcare Medicaid plan.
Wellcare's Part D plans use a 5–6 tier structure: Tier 1 preferred generic costs $0 at preferred pharmacies; Tier 3 preferred brand (where Farxiga typically lands) carries a higher cost-share; and Tier 6 applies to select chronic-condition drugs. A $615 deductible applies before standard tier cost-shares begin. The $2,100 annual out-of-pocket cap limits your total 2026 Part D spending. Wellcare's tier structure has more steps than many competitors — verify your specific tier on the formulary tool.
Generic dapagliflozin is FDA-approved and available. Many Part D plans are updating formularies to cover generic dapagliflozin at a lower tier than brand Farxiga, which could reduce your cost-share significantly. Verify whether Wellcare's 2026 formulary lists generic dapagliflozin and at which tier — it may be Tier 1 or Tier 2 on updated Wellcare formularies. Check at wellcare.com or call member services.
CMS negotiated a Farxiga Maximum Fair Price of $178.50 per 30-day supply, effective January 1, 2026 — a 68% reduction from the prior list price of approximately $556. All Part D plans including Wellcare must apply this as a payer-side ceiling. Whether you personally pay less depends on your plan's cost-sharing structure (copay vs. coinsurance) and benefit phase. The $2,100 annual cap limits your worst-case annual exposure.
Related Articles
Does Aetna Cover Vyvanse? 2026 CVS Caremark Formulary
Aetna covers Vyvanse via CVS Caremark — generic lisdexamfetamine preferred, brand non-preferred. 70 mg/day QL per Policy 5.60.024; age-22 PA required.
Read moreDoes Aetna Cover Prolia? CVS Caremark Medical Benefit | Curex
Aetna covers Prolia under the medical benefit with PA — a q6-month clinic injection, not Part D. Jubbonti biosimilar now preferred on CVS Caremark.
Read moreDoes Anthem Cover Adderall? 2026 Coverage Guide | Curex
Anthem covers Adderall through CarelonRx — generic preferred, brand non-preferred. Step therapy may apply on some plans. Verify your Anthem plan.
Read moreDoes Anthem Cover Contrave? 2026 Brand Coverage Guide | Curex
Anthem covers Contrave only if your plan has a weight-loss benefit. Many plans carve it out. CurAccess ~$99/mo is often the fastest path.
Read moreDoes Aetna Cover Contrave? 2026 CVS Caremark Guide | Curex
Aetna (CVS Caremark) often excludes Contrave under AOM carve-outs. Where covered, CVS BMI prior auth applies. Medicare bars it by law. CurAccess ~$99/mo.
Read moreDoes Aetna Cover Forteo? 2026 Coverage Guide
Aetna (CVS) often excludes brand Forteo in favor of generic teriparatide or Bonsity. Teriparatide is covered with PA and bisphosphonate step therapy. 2026.
Read moreThis content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with Wellcare before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation.